FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286293856> ?p ?o ?g. }

• W4286293856 endingPage "e21144" @default.
• W4286293856 startingPage "e21144" @default.
• W4286293856 abstract "e21144 Background: Anaplastic lymphoma kinase ( ALK) gene rearrangements are found in approximately 5% of non-small-cell lung cancer (NSCLC). Since ALK-TKIs have been developed for patients with ALK-positive advanced NSCLC, it remained 20%-30% non-responders, thus other treatment strategies would be explored to prolong overall survival. Previous studies have shown that ALK rearrangement can upregulate PD-L1 expression via signaling pathways such as ERK/AKT, and the high expression of PD-L1 negatively affects the efficacy of crizotinib and would be more suitable for immunotherapy. However, only a few immunotherapy clinical studies recruited tiny amounts of ALK rearrangement NSCLC, making it difficult to investigate the relationship between this oncogenic gene alteration and therapeutic effects. Herein, we described the immune-related molecular characteristics of ALK-rearranged patients in a large group of Chinese lung cancer, hoping to provide more precise treatment strategies. Methods: A total of 1410 lung cancer patients harboring ALK rearrangement were included in this analysis. Using wide NGS panel testing, we elucidated ALK gene fusions, intergenic region fusions ( ALK-IR) as well as other genomic alterations and TMB levels in each patients’ tumor specimen. PD-L1 expression level was evaluated by the tumor positive score (TPS). Results: Over two hundreds of types of ALK rearrangement were identified. The whole population was divided into six subgroups according to types of ALK rearrangements: 3'- ALK-only (71.1%), 5'-non- EML4-ALK-only (1.0%), multi- ALK fusion (14.2%), single ALK-IR (3.2%), multi-3'- ALK-IR (10.1%), and multi-5'- ALK-IR (0.5%). The overall PD-L1 expression level was high in ALK rearrangement lung cancer, of which the proportion of patients with TPS ≥ 50% was 19.5%, and the TPS ≥ 50% proportion in the single ALK-IR subgroup was the highest (28.6%) among all subgroups. We then evaluated the distribution of TMB levels and found the median TMB level was higher than 30% lung cancer. Of note, the single ALK-IR subgroup also present a trend of higher TMB level among all subgroups. We also observed more DNA damage response (DDR) gene mutations (median number: 2, range: 1-22) in the single ALK-IR subgroup. Somatic copy number amplifications (SCNAs) were detected in 195 (13.8%) ALK -rearranged lung cancer patients, and the proportion of SCNAs in each subgroup was similar. The most frequently high-level amplified genes were MYC (23.9%) and EGFR (10.9%). Furthermore, the 3'- ALK-only subgroup mainly occurred low-level SCNAs (68.5%), whereas the multi- ALK fusion and multi-3'- ALK-IR subgroups were more likely to harbor high and moderate level SCNAs. Conclusions: Our findings demonstrated that lung cancer with ALK-IR might have active immune microenvironment, indicating it’s a subset of ALK-rearranged patients who would benefit from immunotherapy." @default.
• W4286293856 created "2022-07-21" @default.
• W4286293856 creator A5008464615 @default.
• W4286293856 creator A5034729482 @default.
• W4286293856 creator A5048903694 @default.
• W4286293856 creator A5056078581 @default.
• W4286293856 creator A5078275783 @default.
• W4286293856 date "2022-06-01" @default.
• W4286293856 modified "2023-10-14" @default.
• W4286293856 title "Immune-related molecular characteristics of Chinese lung cancer patients with different types of <i>ALK</i> rearrangement." @default.
• W4286293856 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.e21144" @default.
• W4286293856 hasPublicationYear "2022" @default.
• W4286293856 type Work @default.
• W4286293856 citedByCount "0" @default.
• W4286293856 crossrefType "journal-article" @default.
• W4286293856 hasAuthorship W4286293856A5008464615 @default.
• W4286293856 hasAuthorship W4286293856A5034729482 @default.
• W4286293856 hasAuthorship W4286293856A5048903694 @default.
• W4286293856 hasAuthorship W4286293856A5056078581 @default.
• W4286293856 hasAuthorship W4286293856A5078275783 @default.
• W4286293856 hasConcept C104317684 @default.
• W4286293856 hasConcept C111829193 @default.
• W4286293856 hasConcept C117643217 @default.
• W4286293856 hasConcept C121608353 @default.
• W4286293856 hasConcept C126322002 @default.
• W4286293856 hasConcept C143998085 @default.
• W4286293856 hasConcept C2776232967 @default.
• W4286293856 hasConcept C2776256026 @default.
• W4286293856 hasConcept C2777701055 @default.
• W4286293856 hasConcept C2778347629 @default.
• W4286293856 hasConcept C2779422266 @default.
• W4286293856 hasConcept C2908647359 @default.
• W4286293856 hasConcept C2992511266 @default.
• W4286293856 hasConcept C502942594 @default.
• W4286293856 hasConcept C54355233 @default.
• W4286293856 hasConcept C71924100 @default.
• W4286293856 hasConcept C86803240 @default.
• W4286293856 hasConcept C99454951 @default.
• W4286293856 hasConceptScore W4286293856C104317684 @default.
• W4286293856 hasConceptScore W4286293856C111829193 @default.
• W4286293856 hasConceptScore W4286293856C117643217 @default.
• W4286293856 hasConceptScore W4286293856C121608353 @default.
• W4286293856 hasConceptScore W4286293856C126322002 @default.
• W4286293856 hasConceptScore W4286293856C143998085 @default.
• W4286293856 hasConceptScore W4286293856C2776232967 @default.
• W4286293856 hasConceptScore W4286293856C2776256026 @default.
• W4286293856 hasConceptScore W4286293856C2777701055 @default.
• W4286293856 hasConceptScore W4286293856C2778347629 @default.
• W4286293856 hasConceptScore W4286293856C2779422266 @default.
• W4286293856 hasConceptScore W4286293856C2908647359 @default.
• W4286293856 hasConceptScore W4286293856C2992511266 @default.
• W4286293856 hasConceptScore W4286293856C502942594 @default.
• W4286293856 hasConceptScore W4286293856C54355233 @default.
• W4286293856 hasConceptScore W4286293856C71924100 @default.
• W4286293856 hasConceptScore W4286293856C86803240 @default.
• W4286293856 hasConceptScore W4286293856C99454951 @default.
• W4286293856 hasIssue "16_suppl" @default.
• W4286293856 hasLocation W42862938561 @default.
• W4286293856 hasOpenAccess W4286293856 @default.
• W4286293856 hasPrimaryLocation W42862938561 @default.
• W4286293856 hasRelatedWork W2325577077 @default.
• W4286293856 hasRelatedWork W2374768601 @default.
• W4286293856 hasRelatedWork W2516942920 @default.
• W4286293856 hasRelatedWork W2791498761 @default.
• W4286293856 hasRelatedWork W2885292615 @default.
• W4286293856 hasRelatedWork W3176513904 @default.
• W4286293856 hasRelatedWork W3197633853 @default.
• W4286293856 hasRelatedWork W4214618071 @default.
• W4286293856 hasRelatedWork W4242453578 @default.
• W4286293856 hasRelatedWork W4280647591 @default.
• W4286293856 hasVolume "40" @default.
• W4286293856 isParatext "false" @default.
• W4286293856 isRetracted "false" @default.
• W4286293856 workType "article" @default.